BASIS OF PRESENTATION (Details Narrative) |
3 Months Ended | 8 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
|
Mar. 31, 2019
USD ($)
$ / shares
shares
|
May 23, 2019 |
Sep. 30, 2017
USD ($)
$ / shares
shares
|
Jan. 18, 2019
$ / shares
shares
|
Jan. 02, 2019
USD ($)
|
Sep. 30, 2018
$ / shares
shares
|
|
| Gross proceeds from issuance of common stock | $ 19,580,651 | |||||
| Ownership allocation after merger of Company's common stock | 8.90% | |||||
| Common stock, issued | shares | 2,829,248 | 2,829,248 | 56,466,428 | 2,815,748 | ||
| Common stock, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 | $ 0.0001 | $ 0.0001 | ||
| Reverse stock split ratio | 0.05 | |||||
| NeuBaseTherapuetics, Inc. | Dr. Jason Slakter [Member] | ||||||
| Retention bonus amount | $ 75,000 | |||||
| Financing Agreements [Member] | NeuBase Therapeutics, Inc. [Member] | ||||||
| Gross proceeds from issuance of common stock | $ 9,000,000 | |||||
| Termination fee of merger agreement to be paid | $ 250,000 | |||||
| Ownership allocation after merger of Company's common stock | 76.12% |
| X | ||||||||||
- Definition The ownership interest in the merged entity after all transactions have been completed. No definition available.
|
| X | ||||||||||
- Definition The amount of retention bonus resulting from contractual terms due to merger agreement. No definition available.
|
| X | ||||||||||
- Definition The amount of termination fee that may be required to be paid to NeuBase or NeuBase pays the Company under merger agreement. No definition available.
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|